Medistim ASA (LON:0OCD)

Market Cap	294.14M
Revenue (ttm)	44.43M
Net Income (ttm)	9.04M
Shares Out	n/a
EPS (ttm)	0.49
PE Ratio	32.54
Forward PE	30.84
Dividend	0.44 (0.19%)
Ex-Dividend Date	May 9, 2025

Volume	21
Average Volume	464
Open	231.00
Previous Close	220.00
Day's Range	229.00 - 231.00
52-Week Range	133.50 - 231.00
Beta	0.76
RSI	61.23
Earnings Date	Aug 20, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0OCD

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK